Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

Details for Australian Patent Application No. 2010200619 (hide)

Owner Enanta Pharmaceuticals, Inc.

Inventors Nakajima, Suanne; Sun, Ying; Tang, Datong; Xu, Gouyou; Porter, Brian; Or, Yat Sun; Wang, Zhe; Miao, Zhenwei

Agent Griffith Hack

Pub. Number AU-A-2010200619

Parent 2004231987

Filing date 19 February 2010

Wipo publication date 11 March 2010

International Classifications

A61K 31/00 (2006.01)

A61K 31/38 (2006.01) - having sulfur as a ring hetero atom

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07K 5/083 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

4 March 2010 Complete Application Filed

11 March 2010 Application Open to Public Inspection

  Published as AU-A-2010200619

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010200620-Polypeptides

2010200618-Circular Stapler Buttress Combination